Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma
2022 · Journal of Biomedical Science · 23 citations
https://doi.org/10.1186/s12929-022-00873-4
I
I‐Ying Kuo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
798
Citations
18
h-index
20
i10-index
I‐Ying Kuo is an academic researcher from Kaohsiung Medical University. The author has contributed to research in topics: Epigenetics and DNA Methylation & RNA modifications and cancer & Cancer-related gene regulation. The author has an h-index of 18, co-authored 25 publications.
ORCID: 0000-0001-9003-202XPapers by this author
worksDeubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion
2024 · Cell Communication and Signaling · 16 citations
https://doi.org/10.1186/s12964-024-01633-7
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
2020 · Clinical Epigenetics · 14 citations
https://doi.org/10.1186/s13148-020-00878-6
Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer
2024 · Journal of Biomedical Science · 8 citations
https://doi.org/10.1186/s12929-024-01009-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat